TDK Ventures and XTX Ventures participated in a sizeable round raised by the advanced computing technology provider Groq at a unicorn valuation. The company is part of the larger artificial intelligence (AI) space, which has seen much and sustained interest by corporates in recent years.
Category: Analysis
CVC throws off covid gloom in Q1
Analysis: Q1 2021
Corporate venturing hits record highs
Monthly analysis: March 2021
Germany ecosystem wobbles
Innovative region: Germany
Mission for capturing, storing and using carbon
CO2 is the focus but limiting emissions is hard; capturing, using and storing offers opportunities; but critical underinvestment in innovation
Consumer sector goes through pandemic woes
Sector analysis: Consumer
Focus on social media and networks
Netherlands-listed technology investor Prosus, formed out of the corporate venturing assets collected by South Africa-listed media group Naspers, has sold 2% of China-based gaming and social media group Tencent for $14.7bn.
Analysis: Ikena goes public
The oncology drug developer, backed by Bristol Myers Squibb, secured close to $144m in its IPO. This is an exit from a space that has seen much corporate support over the past decade.
Analysis: Lilium to lifts up on $3.3bn reverse merger
Vertical take-off and landing jet developer Lilium went public by joining forces with Nasdaq-listed SPAC.
Analysis: ACV Auctions floats in $416m IPO
The SoftBank-backed automotive e-commerce platform developer ACV Auctions has gone public in an IPO. The company is part of the vehicle marketplace space which has seen much attention from corporate venture investors.
Analysis: Tencent’s IPOs
Overview of three of the largest initial public offerings (IPOs) from 2020 in which the China-based internet company either scored an exit or increased its stake.
Innovation and digitisation mean healthcare is at a tipping point
This is the first in a series of quarterly publications for the Global Health Council looking at drug development, healthcare providers such as hospitals and digital health, payments and patient wellness. This first article looks at the implications of the disease treatments coming out of advanced research and artificial intelligence and the broader shift to digitalisation in healthcare. The next issue will focus on the providers of healthcare.
Corporate venturing continues strong in February
Monthly analysis: February
A shining beacon in the dark
Where do you begin to summarise a year that has been the most challenging on a global scale in living memory?